Biomedical subjects
J Collard
Publications and source records attributed to J Collard.
Antibodies and antigen expression in human melanoma detected by the immune adherence test.
By means of a modified immune adherence (IA) technique, sera from melanoma patients were tested for the presence of antimelanoma antibodies. In total 13/73 sera tested showed a positive IA reaction of which 4/6 sera showed a positive reaction in the autologous situation. Sera from 33 patients with other tumors, 7 patients with non-neoplastic diseases and 50 healthy individuals did not show any IA reactivity towards melanoma cells. The reaction seemed to be selectively directed against tumor-associated antigens (TAA) on melanoma cells. No correlation with the stage of the disease could be found. Longitudinal studies indicated that conversions in antibody activity did not correlate with the clinical state of the patients. There was also no correlation with the corresponding in vitro data obtained in cell-mediated immunity tests. Cell lines and short-term cultures originating from tumors from different melanoma patients shared a common antigenicity. The expression of TAA on cells from a melanoma cell line fluctuated significantly during prolonged culture. The expression of TAA was influenced by the culture conditions and the growth state of the cells. A relation between TAA-expression and cell cycle phase was demonstrated.
The main clinical classifications of neuroleptics.
Explore the source record for details and available documents.
[Chemical control of acute excitation and agitation with injectable clothiapine. II].
Explore the source record for details and available documents.
The first long-acting ("retard") thymoanaleptic or antidepressant: the time-released dibenzepine with prolonged action.
Explore the source record for details and available documents.
Clinical classification of neuroleptics, with special reference to their antimanic, antiautistic, and ataraxic properties.
Explore the source record for details and available documents.
[Control of insomnia using a new benzodiazepine: flunidazepam or Ro 5-4200 (Phase I: Initial investigation. Phase II: Controlled study)].
Explore the source record for details and available documents.
Present treatment of manic states.
Explore the source record for details and available documents.
[Sulpiride, autism and course under MMPI].
Explore the source record for details and available documents.
[Interdisciplinary collaboration in neuropsychopharmacology].
Explore the source record for details and available documents.
A new comparative physiognomy of neuroleptics: a collaborative clinical report.
Explore the source record for details and available documents.
Initial psychopharmacological study of lorazepam (Wy 4036).
Explore the source record for details and available documents.
The place of sulpiride (Dogmatil) in chemotherapy of autism.
Explore the source record for details and available documents.
[Chemical control of excitability of clothiapine or etumine, antimaniacal tranquilizer].
Explore the source record for details and available documents.
Definition and classification of neuroleptics.
Explore the source record for details and available documents.
[Sulpiride, an unusual antiautistic and thymanaleptic neuroleptic agent].
Explore the source record for details and available documents.
[Sulpiride, an unusual neuroleptic anti-autism and thymoanaleptic drug].
Explore the source record for details and available documents.
[Cardiovascular disorders caused by psychotropic drugs and their correction].
Explore the source record for details and available documents.